Sign Up to like & get
recommendations!
0
Published in 2021 at "Therapeutic Drug Monitoring"
DOI: 10.1097/ftd.0000000000000869
Abstract: Background: In inflammatory bowel disease (IBD), conventional thiopurine users cease treatment in 60% of cases within 5 years, mostly because of adverse events or nonresponse. In this study, the authors aimed to investigate the role…
read more here.
Keywords:
inflammatory bowel;
thioguanine nucleotide;
thioguanine;
thiopurine methyltransferase ... See more keywords